We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Popular Inc
BPOP
$11.1B
| $13.8M | 0.08% |
401,325
-285,680
| -42% | -$9.45M |
|
227
MBIA
MBI
$260M
| $13.8M | 0.08% |
1,479,940
+218,864
| +17% | +$1.95M |
|
228
Mid-America Apartment Communities
MAA
$15.7B
| $13.7M | 0.08% |
177,084
-147,257
| -45% | -$11.3M |
|
|
SKX
229
DELISTED
Skechers
SKX
| $13.5M | 0.08% |
565,071
-128,325
| -19% | -$2.76M |
|
230
Synchrony
SYF
$25.6B
| $13.4M | 0.08% |
441,956
+97,948
| +28% | +$3.06M |
|
|
BBBY
231
DELISTED
Bed Bath & Beyond Inc
BBBY
| $13.3M | 0.08% |
172,917
+126,997
| +277% | +$9.63M |
|
232
iShares Russell 2000 ETF
IWM
$81.9B
| $13.1M | 0.08% |
105,295
+4,339
| +4% | +$523K |
|
|
HRG
233
DELISTED
HRG Group, Inc.
HRG
| $12.8M | 0.08% |
1,022,003
-101,886
| -9% | -$1.29M |
|
234
Pearson
PSO
$9.9B
| $12.7M | 0.08% |
587,492
+332,512
| +130% | +$6.88M |
|
235
Walt Disney
DIS
$181B
| $12.6M | 0.08% |
119,839
+101,580
| +556% | +$10.2M |
|
236
Charter Communications
CHTR
$18.2B
| $12.6M | 0.08% |
65,065
+32,393
| +99% | +$5.62M |
|
237
United Parcel Service
UPS
$88.9B
| $12.5M | 0.08% |
+128,824
| New | +$13.2M |
|
238
ICICI Bank
IBN
$108B
| $12.5M | 0.08% |
1,322,323
-3,424,625
| -72% | -$35.5M |
|
239
Barclays
BCS
$94.1B
| $12.3M | 0.08% |
+911,742
| New | +$12.8M |
|
|
ORAN
240
DELISTED
Orange
ORAN
| $12.3M | 0.08% |
767,091
-1,249,241
| -62% | -$21.5M |
|
241
Celestica
CLS
$36.5B
| $12.2M | 0.08% |
1,103,152
+133,620
| +14% | +$1.54M |
|
242
Extra Space Storage
EXR
$31.6B
| $12.2M | 0.08% |
180,766
-48,604
| -21% | -$3.19M |
|
243
Douglas Emmett
DEI
$1.96B
| $12M | 0.07% |
402,827
-263,443
| -40% | -$7.66M |
|
244
LG Display
LPL
$3.3B
| $12M | 0.07% |
838,157
+507,308
| +153% | +$7.84M |
|
245
NVR
NVR
$17B
| $11.9M | 0.07% |
8,988
| – | – |
|
246
Abercrombie & Fitch
ANF
$5B
| $11.9M | 0.07% |
541,328
+11,136
| +2% | +$274K |
|
|
LLL
247
DELISTED
L3 Technologies, Inc.
LLL
| $11.7M | 0.07% |
93,028
-150,969
| -62% | -$19.2M |
|
248
Dr. Reddy's Laboratories
RDY
$10.2B
| $11.6M | 0.07% |
1,018,235
-729,250
| -42% | -$7.74M |
|
249
Mondelez International
MDLZ
$79.9B
| $11.6M | 0.07% |
+322,041
| New | +$11.6M |
|
|
AF
250
DELISTED
Astoria Financial Corporation
AF
| $11.5M | 0.07% |
884,900
-47,021
| -5% | -$603K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.